PMID: 56427Dec 2, 1975

Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial

Journal of Neurology
U K RinneJ Presthus

Abstract

A combination of levodopa and the extracerebrally acting decarboxylase inhibitor benserazide (ratio 4:1) (Madopar), was compared with levodopa alone in a controlled double-blind clinical multicenter trial on 94 patients with Parkinson's disease. During 4 months of therapy levodopa + benserazide proved superior to levodopa on several accounts. Nausea and vomiting occurred with statistically significant less severity and frequency. Clinical improvement expressed through improvement in Webster rating occurred sooner and was all together greater. The treatment schedules did not differ with regard to other side effects, in particular involuntary movements and reduction in supine blood pressure. Neither treatment seemed to influence liver function, renal function and hematological parameters.

References

Apr 9, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stewart A Factor
Aug 1, 1975·Acta Neurologica Scandinavica·E Birket-Smith
May 1, 1976·Acta Neurologica Scandinavica·H PakkenbergU K Rinne
Jan 1, 1979·Current Medical Research and Opinion·B O Williams, D Carlyle
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J E Ahlskog, M D Muenter
Oct 23, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Oscar S Gershanik
Mar 11, 2018·The Journal of Pharmacology and Experimental Therapeutics·Nicolas VeyresPhilippe Huot
Jul 1, 1978·Acta Neurologica Scandinavica·E Birket-SmithB Mikkelsen

Citations

Aug 1, 1975·Acta Neurologica Scandinavica·E Birket-Smith
Jan 1, 1972·Zeitschrift für Neurologie·U K RinneT Sirtola
Jan 1, 1974·Acta Neurologica Scandinavica·E Birket-Smith
Nov 8, 1969·Lancet·D B CalneD R Laurence
Mar 19, 1973·Archiv für Psychiatrie und Nervenkrankheiten·E SchneiderH Maxion
Jan 1, 1973·European Neurology·U K RinneT Siirtola
Jan 1, 1968·European Neurology·U K Rinne, V Sonninen
Sep 1, 1969·British Journal of Pharmacology·D B CalneM Sandler
Jan 1, 1969·Psychopharmacologia·J ConstantinidisF Geissbuhler
Mar 1, 1971·Clinical Pharmacology and Therapeutics·A Pletscher, G Bartholini
Oct 1, 1969·Archives of Neurology·M D YahrM M Hoehn

Related Concepts

Kidney Function Tests
Decarboxylase Inhibitor [EPC]
Diastolic Blood Pressure
Hydrazines
Polychemotherapy
Aromatic Amino Acid Decarboxylase Inhibitors
Decarboxylase inhibitor
Vomiting
Etat Marbre
Nausea and Vomiting

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

European Journal of Clinical Pharmacology
José-Francisco RochaPatrício Soares-da-Silva
Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Rafael Bernardon RibeiroSérgio Paulo Rigonatti
© 2020 Meta ULC. All rights reserved